Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Leen J M HeyensLimburg Clinical Research Center (LCRC), Faculty of Health and Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.ORCID 0000-0003-4850-6011
Francesco InnocentiDepartment of Methodology and Statistics, Care and Public Health Research Institute (CAPHRI), Maastricht University, 6211 LK Maastricht, The Netherlands.ORCID 0000-0001-6113-8992
Christophe Van SteenkisteDepartment of Gastroenterology and Hepatology, AZ Maria Middelares, 9000 Gent, Belgium.
Mathieu StruyveDepartment of Gastroenterology, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Sven M FrancqueDepartment of Gastroenterology and Hepatology, Antwerp University Hospital, 2000 Antwerp, Belgium.ORCID 0000-0002-7527-4714
Ger H KoekSchool of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, 6211 LK Maastricht, The Netherlands.
Geert RobaeysLimburg Clinical Research Center (LCRC), Faculty of Health and Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.
On Behalf Of The Masld Research Group
Funding
CAPHRI School for Public Health and Primary Care N.A.CARIM School for Cardiovascular Diseases N.A.Dutch Diabetes Research Foundation 2016.22.1878European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs 31O.041Fonds Wetenschappelijk Onderzoek Vlaanderen 1802154NFonds Wetenschappelijk Onderzoek Vlaanderen 1S73421NHealth Foundation Limburg N.A.Janssen-Cilag B.V. N.A.Medtronic N.A.Novo Nordisk Farma B.V. N.A.NUTRIM School for Nutrition and Translational Research in Metabolism N.A.Pearl String Initiative Diabetes N.A.Perimed (Sweden) N.A.Sanofi-Aventis Netherlands B.V. N.A.Stichting De Weijerhorst N.A.Stichting Oogfonds Nederland N.A.the Cardiovascular Center N.A.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The Netherlands. · full record | Socratic